Key messages

• Teledermatology for Advice & Guidance and Referrals
• August 22: ADHD and Autism FAQ
• July 22: Update to the Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment
• Waiting Times for Routine Care
• Diabetic Eye Screening Programme (DESP)
• Hydroxychloroquine Retinopathy Monitoring
• UHP Nurse-led Hypoglycaemia Assessment & Intervention for Positive Outcomes Project (HAIPO)
• Expediting Referrals – how to communicate with Secondary Care
• Devon patient choice statement
• Torbay and South Devon Pre-choice Triage/Advice & Guidance
• UHP Pre-choice Triage/Advice & Guidance

Referral updates

• 23/01/2023: New Gout Clinical Referral Guideline - Torbay and South Devon locality
• 23/01/2023: New Gout Clinical Referral Guideline - Western locality
• 02/12/2022: Update to the Colorectal (lower GI) 2WW Clinical Referral Guideline - Torbay and South Devon locality
• 02/12/2022: Update to the Colorectal (lower GI) 2WW Clinical Referral Guideline - Western locality
• 07/11/2022: Update to the Diabetic Footcare Clinical Referral Guideline - Western locality
• 26/09/2022: New Rapid access clinic for Paediatric Dietitian referral for infants with Cow’s Milk Protein Allergy (CMPA) - UHP
• 29/07/2022: New Post COVID Syndrome (PCS) in Children and Young People Clinical Referral Guideline - Torbay and South Devon locality
• 29/07/2022: New Post COVID Syndrome (PCS) in Children and Young People Clinical Referral Guideline - Western locality
• 15/07/2022: Update to the Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment

Referral feedback

• To contact the Clinical Referral Guideline Support Team